Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Procrit Market Expansion Outlook: What Revenue Opportunities Are Ahead?
The historical period experienced growth primarily due to the growing incidence of chronic kidney disease, the rise in chemotherapy-induced anemia cases, the uptake of biologic anemia therapies, the expansion of dialysis treatment centers, and improved availability of prescription anemia drugs.
The anticipated market expansion during the forecast period is primarily driven by a greater emphasis on tailored anemia treatment strategies, the growing embrace of biosimilar options, the broadening scope of chronic illness management initiatives, an increasing priority placed on enhancing patient well-being, and heightened capital allocation towards refining biologic medications. Concurrently, significant patterns emerging during this period will involve a rise in the application of erythropoiesis-stimulating agents, an uptick in the need for anemia treatment solutions, the broadening of supportive care options for oncology patients, a heightened commitment to minimizing the necessity for blood transfusions, and more rigorous oversight of persistent anemic states.
Get A Free Sample Report With In-Depth Market Insights:
Procrit Market Demand Drivers: What’s Powering Industry Growth?
A projected rise in anemia cases is anticipated to boost the Procrit market. This condition involves an insufficient count of healthy red blood cells or hemoglobin, leading to inadequate oxygen supply to the body’s tissues. Factors contributing to this increase include a growing worldwide burden of chronic illnesses like kidney failure, cancer, and inflammatory conditions, alongside inadequate nutrition causing iron, vitamin B12, and folate deficiencies. Procrit (epoetin alfa) addresses anemia stemming from chronic kidney disease, chemotherapy, or specific HIV therapies. It functions by encouraging red blood cell formation, thereby lessening the requirement for blood transfusions in individuals with low hemoglobin. For example, data from the US-based National Center for Health Statistics reported in December 2024 indicated a 9.3% rise in anemia prevalence among individuals aged 2 and above in 2023 compared to 2021. Consequently, the expanding prevalence of anemia is a key driver for the Procrit market. The Procrit market is set to be driven by the growing incidence of chronic kidney diseases. This ailment involves the progressive decline in the kidneys’ capacity to cleanse waste from the bloodstream. Reasons for this surge include an aging global population, obesity, and lifestyle choices combined with environmental influences. Procrit (epoetin alfa) aids chronic kidney disease patients by treating anemia through stimulated red blood cell production, assisting in sustaining proper hemoglobin levels, and diminishing the necessity for blood transfusions. As an illustration, a June 2023 report from Kidney Research UK, a non-profit organization, stated that around 7.2 million people in the UK currently suffer from chronic kidney disease, accounting for over 10% of the population. Among these, 3.25 million are in advanced stages, and 3.9 million are in early stages. Projections indicate that by 2033, this figure will climb to 7.61 million. Thus, the increasing occurrence of chronic kidney diseases fuels the Procrit market.
Procrit Market Segmentation: How Does The Market Break Down By Category?
The procrit market covered in this report is segmented –
1) By Indications: Chronic Kidney Diseases, Human Immunodeficiency Virus (HIV) Infection, Chemotherapy
2) By Distribution Channel: Direct Sales, Pharmaceutical Wholesalers, Retail Pharmacies
3) By End Users: Hospitals, Outpatient Clinics, Home Care
Procrit Market Competitive Overview And Top Companies
Major companies operating in the procrit market are Amgen Inc.
View The Full Procrit Market Report:
Procrit Market Geographic Spread And Regional Opportunities
North America was the largest region in the procrit market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the procrit market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
